van der Burg Sjoerd H, Piersma Sytse J, de Jong Annemieke, van der Hulst Jeanette M, Kwappenberg Kitty M C, van den Hende Muriel, Welters Marij J P, Van Rood Jon J, Fleuren Gert Jan, Melief Cornelis J M, Kenter Gemma G, Offringa Rienk
Department of Clinical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12087-92. doi: 10.1073/pnas.0704672104. Epub 2007 Jul 5.
Because of their important role in the maintenance of self-tolerance, CD4(+) regulatory T cells prevent autoimmune diseases but also curtail the efficacy of T cell immune responses against cancers. We now show that this suppressive action of CD4(+) regulatory T cells is not limited to cancers displaying tumor-associated self antigens, such as melanomas, but also extends to human papillomavirus (HPV)-positive cervical cancers that express foreign tumor antigens. HPV-specific CD4(+) T cells isolated from lymph node biopsies of cervical cancer patients were found to suppress proliferation and cytokine (IFN-gamma, IL-2) production by responder T cells. The capacity of HPV-specific CD4(+) T cells to exert this suppressive effect depended on their activation by cognate HPV antigen and on close-range interactions with responder T cells. HPV-specific CD4(+) regulatory T cells were also retrieved from cervical cancer biopsies, suggesting that they interfere with the anti-tumor immune response at both the induction and effector levels. Our findings offer a plausible explanation for the observed failure of the tumor-specific immune response in patients with cervical carcinoma.
由于CD4(+)调节性T细胞在维持自身耐受性方面发挥重要作用,它们既能预防自身免疫性疾病,也会削弱针对癌症的T细胞免疫反应的效力。我们现在发现,CD4(+)调节性T细胞的这种抑制作用不仅限于显示肿瘤相关自身抗原的癌症,如黑色素瘤,还扩展到表达外来肿瘤抗原的人乳头瘤病毒(HPV)阳性宫颈癌。从宫颈癌患者淋巴结活检中分离出的HPV特异性CD4(+) T细胞被发现可抑制反应性T细胞的增殖和细胞因子(IFN-γ、IL-2)产生。HPV特异性CD4(+) T细胞发挥这种抑制作用的能力取决于它们被同源HPV抗原激活以及与反应性T细胞的近距离相互作用。HPV特异性CD4(+)调节性T细胞也从宫颈癌活检中被检出,这表明它们在诱导和效应水平均干扰抗肿瘤免疫反应。我们的研究结果为观察到的宫颈癌患者肿瘤特异性免疫反应失败提供了一个合理的解释。